Horizon Pharma PLC will continue to grow its orphan drug portfolio through acquisitions like the $800m purchase of Raptor Pharmaceutical Corp. announced on Sept. 12, but Horizon's primary care b
A poor first quarter for Dublin, Ireland-headquartered Horizon Pharma PLC 's primary care business leading it to lower its full-year revenue guidance and causing a 35% share price plunge on May 8 h
IN VITRO DIAGNOSTICS Mergers & Acquisitions Immucor Inc. Organ-I Inc. Immucor Inc. acquired fellow privately held transplant diagnostics company Organ-I Inc. (Jun.) Organ-I spun out of Stanf
Financings During the opening quarter of 2014, biopharma companies raised $9.8 billion (up 53% from Q4), with 18% of the deals having a value of $100 million or greater. ( See Exhibit 1. ) Follow-on p